Rosenberg, S A <br/><br/>
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 1999 
 - 968-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1999.17.3.968  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Dacarbazine--administration & dosage<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Prospective Studies<br/>Recombinant Proteins<br/>Remission Induction<br/>Tamoxifen--administration & dosage